Light Treatment to Improve Symptom Management of Fibromyalgia Syndrome

University of Michigan

Status: Completed

Conditions: Fibromyalgia; FMS

Treatments: Device: Light therapy B (Dim) via the Re-Timer®; Device: Light therapy A (Bright) via the Re-Timer®

Study type: Interventional

Funder types: Other; NIH

Identifiers

NCT03794908

1R21NR016930-01A1 (U.S. NIH Grant/Contract)

HUM00151160

Details and patient eligibility

About

The purpose of this study is to determine the effect a morning light treatment has on improving physical function, pain intensity, and pain sensitivity in people with fibromyalgia syndrome (FMS).

Enrollment: 60 patients

Sex: All

Ages: 18+ years old

Volunteers: No Healthy Volunteers

Inclusion criteria

• Meet criteria for Fibromyalgia syndrome (FMS)

Exclusion criteria

• Significant chronic disease
• Severe hearing or memory problems
• Pending medical leave applications at workplace
• Current pregnancy, breastfeeding, or actively trying to get pregnant
• Night work or travel outside the eastern time zone within 1 month of the study
• Other research participation
• Frequent number of special events during study period (weddings, concerts, exams, etc).

Trial design

Primary purpose: Supportive Care

Allocation: Randomized

Interventional model: Parallel Assignment

Masking: Double Blind

---

60 participants in 2 patient groups

Light therapy A (Bright) via the Re-Timer®

Experimental group

Description:

60 minutes/day For the first hour after waking

Treatment:

Device: Light therapy A (Bright) via the Re-Timer®

Light therapy B (Dim) via the Re-Timer®

Active Comparator group

Description:

60 minutes/day For the first hour after waking

Treatment:

Device: Light therapy B (Dim) via the Re-Timer®